LOVE Pharma has appointed Joshua Maurice as its Chief Operating Officer - YouTube

Channel: InvestmentPitch Media

[2]
I’m Katriina Cotten for Investmentpitch Media
[11]
LOVE Pharma Inc., an international sexual health, wellness, and psychedelics company,
[16]
has appointed Joshua Maurice as its Chief Operating Officer.
[20]
Mr. Maurice brings 20 years of experience in consumer goods with a focus on the development
[26]
of over-the-counter drug and nutraceuticals, including efficacy, clinical research, branding,
[32]
marketing, advertising, and global retail distribution.
[36]
He was most recently at Callitas Therapeutics where over 4 years he quickly rose through
[41]
the ranks from Director of Sales & Marketing to VP of Sales & Business Development and
[47]
then to President.
[48]
Having successfully launched a number of retail brands from concept to distribution, both
[53]
direct-to-consumer and with brick-and-mortar retailers including Walmart, CVS, Target,
[59]
and Walgreens, Mr. Maurice's track record in streamlining manufacturing and supply chain
[64]
management, while maximizing profitability and product performance should prove invaluable
[69]
to LOVE Pharma.
[71]
Joshua Maurice, COO, stated: “While I am truly impressed by the breadth of the LOVE
[77]
Pharma portfolio-ranging from CBD and psychedelics to sexual wellness and conception-it's being
[84]
ideally positioned to bring novel health and wellness products to market that really excites
[89]
me about joining the LOVE Pharma team; and I look forward to focusing on how our innovative
[94]
technologies can legitimately improve the lives of our customers.”
[97]
In his new role at LOVE Pharma, Mr. Maurice will be responsible for the following:
[104]
Overseeing day-to-day operations, including logistics and supply chain systems
[109]
Directing the acquisition of new technologies as well as product development
[113]
Steering the launch of new products, including key branded products such as BLOOM™ and
[118]
AURALIEF™, and their respective marketing and advertising campaigns
[123]
Leading contract negotiations and vendor acquisitions
[128]
Zachary Stadnyk, CEO, added: “Joshua's expertise is exactly what we need to properly execute
[134]
the rollout of new products as well as to oversee the distribution and marketing of
[139]
our strong portfolio of therapeutic and pharmaceutical products. We welcome Joshua, a talented senior
[146]
executive with years of experience, to the LOVE Pharma team, where his guidance and history
[151]
will make him an invaluable asset; and we look forward to the future growth and expansion
[156]
that he will lead.”
[158]
Founded in 2020, LOVE Pharma is focused on the Global Sexual Health, Wellness, and Psychedelics
[165]
markets, with a mission to bring to market innovative products that enhance sexual health
[169]
and wellness while providing an improved quality of life.
[173]
LOVE Pharma holds exclusive licenses to produce market, package, sell, and distribute patent-protected
[180]
therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.
[186]
The company is initially launching Bloom, a topical gel that increases blood circulation
[192]
and sensitivity, with future hemp-infused versions, designed to further improve blood
[197]
circulation and sensitivity, along with Auralief, a discreet cannabis-infused oral strip that
[204]
expedites and enhances the desired effects of THC and CBD.
[208]
The company has a number of other proven products in the pipeline to aid in mental and sexual
[213]
health and wellness.
[215]
The company is also actively seeking additional mergers and acquisitions to complement its
[220]
strong portfolio of intellectual property.
[223]
The shares which began trading on the CSE on September 30, are trading at $0.08.
[229]
For more information, please visit the company’s website www.love-pharma.com, contact Zach
[235]
Stadnyk, President and CEO, at 604-343-2977 or by email at [email protected].